• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有BRCA1致病变异的女性的生育次数、母乳喂养与早发性乳腺癌风险

Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant.

作者信息

Kotsopoulos Joanne, Maxwell Christopher A, Lubinski Jan, Huzarski Tomasz, Kim Raymond H, Tung Nadine, Eisen Andrea, Foulkes William, Aeilts Amber, Neuhausen Susan L, Bordeleau Louise, Khokha Rama, Pal Tuya, Karlan Beth, Fruscio Robert, Couch Fergus, Sun Ping, Gronwald Jacek, Narod Steven A

机构信息

Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.

Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

出版信息

Br J Cancer. 2025 May 2. doi: 10.1038/s41416-025-03029-x.

DOI:10.1038/s41416-025-03029-x
PMID:40316726
Abstract

BACKGROUND

It is not clear if breastfeeding and/or parity are associated with the risk of breast cancer among women with a germline pathogenic variant in BRCA1. We sought to evaluate the associations of these two factors with early-onset breast cancer in the BRCA1 pathogenic variant.

METHODS

This case-control study included individuals with a BRCA1 pathogenic variant enroled in a longitudinal study using reproductive and disease histories ascertained at the time of enrolment. Cases had invasive breast cancer prior to age 45, and controls had no breast cancer prior to age 45. Logistic regression was used to evaluate the associations of parity and breastfeeding with cancer risk.

RESULTS

Parity per se was not associated with breast cancer risk (OR = 1.09; 95%CI 0.95-1.25); however, among women who never breastfed, the OR for parous vs. nulliparous women was 1.45 (95%CI 1.20-1.75). After matching for parity, ever breastfeeding was associated with 25% lower odds of breast cancer (95%CI 0.61-0.91), and the odds ratio was 0.53 (95%CI 0.40-0.72) for those who breastfed for 20 or more months.

DISCUSSION

Our findings suggest a potential role for breastfeeding in the prevention of young-onset breast cancer among individuals with a BRCA1 pathogenic variant and provide insight into possible prevention targets.

摘要

背景

在携带BRCA1基因种系致病性变异的女性中,母乳喂养和/或生育状况是否与患乳腺癌风险相关尚不清楚。我们试图评估这两个因素与携带BRCA1致病性变异的早发性乳腺癌之间的关联。

方法

这项病例对照研究纳入了参与一项纵向研究的携带BRCA1致病性变异的个体,该研究利用入组时确定的生殖和疾病史。病例为45岁之前患浸润性乳腺癌的患者,对照为45岁之前未患乳腺癌的个体。采用逻辑回归评估生育状况和母乳喂养与癌症风险的关联。

结果

生育本身与乳腺癌风险无关(比值比[OR]=1.09;95%置信区间[CI]为0.95-1.25);然而,在从未母乳喂养的女性中,经产妇与未产妇相比的OR为1.45(95%CI为1.20-1.75)。在对生育状况进行匹配后,曾经母乳喂养与乳腺癌几率降低25%相关(95%CI为0.61-0.91),母乳喂养20个月或更长时间者的比值比为0.53(95%CI为0.40-0.72)。

讨论

我们的研究结果表明,母乳喂养在预防携带BRCA1致病性变异个体的年轻女性乳腺癌中可能发挥作用,并为可能的预防靶点提供了见解。

相似文献

1
Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant.具有BRCA1致病变异的女性的生育次数、母乳喂养与早发性乳腺癌风险
Br J Cancer. 2025 May 2. doi: 10.1038/s41416-025-03029-x.
2
Analysis of the conditions for applying BRCA genetic testing to women with breast cancer using the Japanese HBOC consortium and the Japanese organization of hereditary breast and ovarian cancer (JOHBOC) registry project database.利用日本遗传性乳腺癌和卵巢癌联盟(HBOC)以及日本遗传性乳腺癌和卵巢癌组织(JOHBOC)登记项目数据库,分析对乳腺癌女性应用BRCA基因检测的条件。
Breast Cancer. 2025 May 5. doi: 10.1007/s12282-025-01704-8.
3
Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.生殖因素、绝经激素治疗与原发性肝癌风险:观察性研究的系统评价和剂量-反应荟萃分析。
Hum Reprod Update. 2016 Dec;23(1):126-138. doi: 10.1093/humupd/dmw037. Epub 2016 Sep 21.
4
Duration of Breastfeeding and Risk Reduction of Breast Cancer among Mothers Who Have Ever Breastfed: A Case-Control Study Conducted in Bahir Dar, Ethiopia.曾经母乳喂养的母亲的母乳喂养持续时间与降低患乳腺癌风险:在埃塞俄比亚巴赫达尔进行的一项病例对照研究
Breast J. 2024 Sep 21;2024:1987378. doi: 10.1155/2024/1987378. eCollection 2024.
5
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.对携带BRCA1或BRCA2基因突变的女性进行降低风险的双侧输卵管卵巢切除术。
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.
6
Maternal and neonatal outcomes of elective induction of labor.择期引产的母婴结局
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.
7
Support for healthy breastfeeding mothers with healthy term babies.支持健康足月婴儿的母乳喂养母亲。
Cochrane Database Syst Rev. 2022 Oct 25;10(10):CD001141. doi: 10.1002/14651858.CD001141.pub6.
8
A Dominantly Inherited 5' UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer.一个显性遗传的 5'UTR 变异导致 BRCA1 的甲基化相关沉默,是乳腺癌和卵巢癌的原因之一。
Am J Hum Genet. 2018 Aug 2;103(2):213-220. doi: 10.1016/j.ajhg.2018.07.002.
9
The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South Indians.印度乳腺癌和卵巢癌中的 BRCA 突变谱:强调在印度南部人群中筛查 BRCA1 185delAG 的必要性。
Eur J Hum Genet. 2024 Oct;32(10):1319-1326. doi: 10.1038/s41431-024-01596-w. Epub 2024 Mar 28.
10
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.

本文引用的文献

1
Targeting DNA damage response pathways in cancer.靶向癌症中的DNA损伤反应通路。
Nat Rev Cancer. 2023 Feb;23(2):78-94. doi: 10.1038/s41568-022-00535-5. Epub 2022 Dec 5.
2
Hormonal regulation of mammary gland development and lactation.激素对乳腺发育和泌乳的调节。
Nat Rev Endocrinol. 2023 Jan;19(1):46-61. doi: 10.1038/s41574-022-00742-y. Epub 2022 Oct 3.
3
Breastfeeding reduces the risk of breast cancer: A call for action in high-income countries with low rates of breastfeeding.母乳喂养可降低乳腺癌风险:呼吁在母乳喂养率低的高收入国家采取行动。
Cancer Med. 2023 Feb;12(4):4616-4625. doi: 10.1002/cam4.5288. Epub 2022 Sep 26.
4
Pathogenic BRCA1 variants disrupt PLK1-regulation of mitotic spindle orientation.致病性 BRCA1 变异破坏 PLK1 对有丝分裂纺锤体取向的调控。
Nat Commun. 2022 Apr 22;13(1):2200. doi: 10.1038/s41467-022-29885-2.
5
The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With or Mutations.怀孕次数和时间对有特定基因突变或携带特定突变的女性患乳腺癌风险的影响
JNCI Cancer Spectr. 2018 Dec;2(4):pky078. doi: 10.1093/jncics/pky078. Epub 2019 Mar 8.
6
Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses' Health Studies.同型生育、母乳喂养与激素受体状态和分子表型乳腺癌风险的关系:来自护士健康研究的结果。
Breast Cancer Res. 2019 Mar 12;21(1):40. doi: 10.1186/s13058-019-1119-y.
7
Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies.近期分娩后乳腺癌风险:15 项前瞻性研究的汇总分析。
Ann Intern Med. 2019 Jan 1;170(1):22-30. doi: 10.7326/M18-1323. Epub 2018 Dec 11.
8
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.BRCA1 和 BRCA2 基因突变携带者的乳腺癌、卵巢癌和对侧乳腺癌风险。
JAMA. 2017 Jun 20;317(23):2402-2416. doi: 10.1001/jama.2017.7112.
9
RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.RANK 配体作为 BRCA1 突变携带者乳腺癌预防的潜在靶点。
Nat Med. 2016 Aug;22(8):933-9. doi: 10.1038/nm.4118. Epub 2016 Jun 20.
10
Essential role for a novel population of binucleated mammary epithelial cells in lactation.一类新型双核乳腺上皮细胞在泌乳过程中的重要作用。
Nat Commun. 2016 Apr 22;7:11400. doi: 10.1038/ncomms11400.